Melanoma, cutaneous malignant, susceptibility to, 2
MONDO:0007964Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed)
Also known as: Atypical Mole syndrome, B-K Mole syndrome, dysplastic nevus syndrome, familial dysplastic nevi, melanoma, cutaneous malignant, 2, melanoma, cutaneous malignant, susceptibility to, 2, melanoma, cutaneous malignant, susceptibility to, type 2, CMM2
38 clinical trials for this condition and its sub-types, 6 tagged with Melanoma, cutaneous malignant, susceptibility to, 2 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
A watchful eye: could alternating scans outsmart pancreatic cancer?
Diagnosis CompletedThis study follows people with a significantly elevated risk of pancreatic cancer—due to inherited gene mutations or strong family history—who choose to undergo early detection testing. Participants receive endoscopic ultrasound (EUS) and MRI scans on an alternating schedule ever…
Sponsor: White Plains Hospital • Aim: Diagnosis
Last updated Aug 27, 2026 00:00 UTC
-
Could a simple skin zap spot melanoma sooner?
Diagnosis CompletedThis study looked at whether a device called Nevisense, which measures the electrical properties of moles, can help doctors better assess suspicious moles during routine skin checks. Forty adults with many moles (at least 100) and several large moles took part. The goal is to imp…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC